FDA action breaks regulatory gridlockPatience is a virtue, especially for medical imaging companieswith new products stuck in the review process at the Food andDrug Administration. Acoustic Imaging of Phoenix was one suchcompany. The ultrasound
Patience is a virtue, especially for medical imaging companieswith new products stuck in the review process at the Food andDrug Administration. Acoustic Imaging of Phoenix was one suchcompany. The ultrasound vendor found its patience sorely testedas its 510(k) application for a 3-D ultrasound workstation languishedat the FDA for nearly two and a half years.
This story has a happy ending, however. Acoustic Imaging announcedlast week that the FDA has cleared its 3-D Ultrasound ImagingWorkstation. AI is believed to be the first company with a 3-Dultrasound reconstruction product on the market. Cone Instrumentsof Solon, OH, and Tomographic Technologies of El Toro, CA, arestill waiting for FDA clearance for their products.
Acoustic Imaging unveiled the workstation at the 1991 RadiologicalSociety of North America meeting and began placing the systemin beta sites shortly thereafter (SCAN 10/21/92). AI filed a 510(k)application with the FDA in July of 1992.
The workstation uses a 3-D probe with a stepping motor thatmoves the transducer in increments to acquire 2-D slices. Theslices are converted to digital form by a video frame-grabberand transferred to the workstation. The workstation runs on dualmicroprocessors, an Intel 486 chip for basic tasks and an IntelI860 for 3-D rendering.
Acoustic Imaging is continuing to work with luminary sitesto monitor performance and develop clinical applications for theworkstation. The company said that users at its clinical sitesbelieve the workstation could prove useful in obstetrical, prostateand breast imaging. AI will adopt a conservative tack in distributingits new technology: The vendor plans to focus on shipping theworkstation to selected research sites, rather than making a blockbusterproduct introduction.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.